Consumer Affairs - "Opioid-Related Deaths Affecting Average Life Expectancy In The US" - Christopher Maynard
A Centers for Disease Control Prevention study finds that opioid-related poisoning deaths more than triples from 2000 to 2015 in the US, and that they are a significant factor in reducing the country’s average life expectancy. The National Institute on Drug Abuse said that 2.5 million Americans currently suffer from opioid use disorder, but there are effective medications that can treat it. The World Health Organization has classified buprenorphine and methadone as “essential medicines” for treating opioid addiction, but experts said that these drugs should be used in conjunction with other interventions for the best outcomes. Unfortunately, one of the most-cited drawbacks of these medicinal treatments are that they themselves can become addictive to users. This is particularly true of methadone, which has been connected to a large number of overdose deaths in its own right. Researchers from the Icahn School of Medicine at Mount Sinai are currently working on a new class of medications that would be non-addictive and less harmful to consumers. While these drugs are currently being tested and may not be available to patients for some time, lead investigator Marta Filizola, PhD, professor of pharmacological sciences, neuroscience and dean of the graduate school of biomedical sciences at the Icahn School of Medicine at Mount Sinai, is committed to attacking the opioid overdose epidemic with effective alternatives.
- Marta Filizola, PhD, Professor, Pharmacological Sciences, Neuroscience, Dean, The Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai